Review: effectiveness of ACE inhibitors is similar across various baseline risks for disease progression in nondiabetic nephropathy
- PMID: 18170999
Review: effectiveness of ACE inhibitors is similar across various baseline risks for disease progression in nondiabetic nephropathy
Comment on
-
Progression risk, urinary protein excretion, and treatment effects of angiotensin-converting enzyme inhibitors in nondiabetic kidney disease.J Am Soc Nephrol. 2007 Jun;18(6):1959-65. doi: 10.1681/ASN.2006101081. Epub 2007 May 2. J Am Soc Nephrol. 2007. PMID: 17475813
Publication types
LinkOut - more resources
Miscellaneous